LIST OF TABLES
TABLE 1. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR DIALYSATES AND REPLACEMENT FLUIDS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR DIALYSATES AND REPLACEMENT FLUIDS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR DISPOSABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FOR HEMOFILTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FOR BLOODLINE SETS & TUBES, BY REGION, 2021-2031 ($MILLION)
TABLE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FOR OTHER DISPOSABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR CRRT SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR CRRT SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH), BY REGION, 2021-2031 ($MILLION)
TABLE 14. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF), BY REGION, 2021-2031 ($MILLION)
TABLE 16. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR CONTINUOUS VENOVENOUS HAEMODIALYSIS (CVVHD), BY REGION, 2021-2031 ($MILLION)
TABLE 18. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR CONTINUOUS VENOVENOUS HAEMODIALYSIS (CVVHD), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR SLOW CONTINUOUS ULTRAFILTRATION (SCUF), BY REGION, 2021-2031 ($MILLION)
TABLE 20. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR SLOW CONTINUOUS ULTRAFILTRATION (SCUF), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 22. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR ADULTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR PEDIATRICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. U.S. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 33. U.S. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 34. U.S. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 35. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 37. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 38. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 40. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 41. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. EUROPE DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 43. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 44. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 45. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 48. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 49. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 51. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 52. UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 54. UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 55. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 57. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 58. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 60. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 70. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 71. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 72. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 74. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 75. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 76. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 77. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 84. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 87. LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. LAMEA DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 89. LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 90. LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 91. LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 92. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 94. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 97. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 100. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2021-2031 ($MILLION)
TABLE 103. REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 104.FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT
TABLE 105.FRESENIUS MEDICAL CARE: OPERATING SEGMENTS
TABLE 106.FRESENIUS MEDICAL CARE: PRODUCT PORTFOLIO
TABLE 107.FRESENIUS MEDICAL CARE: NET SALES,
TABLE 108.FRESENIUS MEDICAL CARE: KEY STRATERGIES
TABLE 109.BAXTER INTERNATIONAL: COMPANY SNAPSHOT
TABLE 110.BAXTER INTERNATIONAL: OPERATING SEGMENTS
TABLE 111.BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 112.BAXTER INTERNATIONAL: NET SALES,
TABLE 113.BAXTER INTERNATIONAL: KEY STRATERGIES
TABLE 114.TORAY INDUSTRIES INC.: COMPANY SNAPSHOT
TABLE 115.TORAY INDUSTRIES INC.: OPERATING SEGMENTS
TABLE 116.TORAY INDUSTRIES INC.: PRODUCT PORTFOLIO
TABLE 117.TORAY INDUSTRIES INC.: NET SALES,
TABLE 118.TORAY INDUSTRIES INC.: KEY STRATERGIES
TABLE 119.SWS HEMODIALYSIS CARE: COMPANY SNAPSHOT
TABLE 120.SWS HEMODIALYSIS CARE: OPERATING SEGMENTS
TABLE 121.SWS HEMODIALYSIS CARE: PRODUCT PORTFOLIO
TABLE 122.SWS HEMODIALYSIS CARE: NET SALES,
TABLE 123.SWS HEMODIALYSIS CARE: KEY STRATERGIES
TABLE 124.NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 125.NIPRO CORPORATION: OPERATING SEGMENTS
TABLE 126.NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 127.NIPRO CORPORATION: NET SALES,
TABLE 128.NIPRO CORPORATION: KEY STRATERGIES
TABLE 129.NINGBO TIANYI MEDICAL DEVICES: COMPANY SNAPSHOT
TABLE 130.NINGBO TIANYI MEDICAL DEVICES: OPERATING SEGMENTS
TABLE 131.NINGBO TIANYI MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 132.NINGBO TIANYI MEDICAL DEVICES: NET SALES,
TABLE 133.NINGBO TIANYI MEDICAL DEVICES: KEY STRATERGIES
TABLE 134.NIKKISO CO. LTD: COMPANY SNAPSHOT
TABLE 135.NIKKISO CO. LTD: OPERATING SEGMENTS
TABLE 136.NIKKISO CO. LTD: PRODUCT PORTFOLIO
TABLE 137.NIKKISO CO. LTD: NET SALES,
TABLE 138.NIKKISO CO. LTD: KEY STRATERGIES
TABLE 139.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 140.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 141.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 142.MEDTRONIC PLC: NET SALES,
TABLE 143.MEDTRONIC PLC: KEY STRATERGIES
TABLE 144.MEDITES PHARMA SPOL. S.R.O: COMPANY SNAPSHOT
TABLE 145.MEDITES PHARMA SPOL. S.R.O: OPERATING SEGMENTS
TABLE 146.MEDITES PHARMA SPOL. S.R.O: PRODUCT PORTFOLIO
TABLE 147.MEDITES PHARMA SPOL. S.R.O: NET SALES,
TABLE 148.MEDITES PHARMA SPOL. S.R.O: KEY STRATERGIES
TABLE 149.MEDICAL COMPONENTS INC.: COMPANY SNAPSHOT
TABLE 150.MEDICAL COMPONENTS INC.: OPERATING SEGMENTS
TABLE 151.MEDICAL COMPONENTS INC.: PRODUCT PORTFOLIO
TABLE 152.MEDICAL COMPONENTS INC.: NET SALES,
TABLE 153.MEDICAL COMPONENTS INC.: KEY STRATERGIES
TABLE 154.MEDICA S.P.A: COMPANY SNAPSHOT
TABLE 155.MEDICA S.P.A: OPERATING SEGMENTS
TABLE 156.MEDICA S.P.A: PRODUCT PORTFOLIO
TABLE 157.MEDICA S.P.A: NET SALES,
TABLE 158.MEDICA S.P.A: KEY STRATERGIES
TABLE 159.INFOMED SA: COMPANY SNAPSHOT
TABLE 160.INFOMED SA: OPERATING SEGMENTS
TABLE 161.INFOMED SA: PRODUCT PORTFOLIO
TABLE 162.INFOMED SA: NET SALES,
TABLE 163.INFOMED SA: KEY STRATERGIES
TABLE 164.CYTOSORBENTS: COMPANY SNAPSHOT
TABLE 165.CYTOSORBENTS: OPERATING SEGMENTS
TABLE 166.CYTOSORBENTS: PRODUCT PORTFOLIO
TABLE 167.CYTOSORBENTS: NET SALES,
TABLE 168.CYTOSORBENTS: KEY STRATERGIES
TABLE 169.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY: COMPANY SNAPSHOT
TABLE 170.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY: OPERATING SEGMENTS
TABLE 171.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 172.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY: NET SALES,
TABLE 173.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY: KEY STRATERGIES
TABLE 174.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 175.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 176.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 177.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 178.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 179.ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
TABLE 180.ASAHI KASEI CORPORATION: OPERATING SEGMENTS
TABLE 181.ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
TABLE 182.ASAHI KASEI CORPORATION: NET SALES,
TABLE 183.ASAHI KASEI CORPORATION: KEY STRATERGIES
TABLE 184.ANJUE MEDICAL EQUIPMENT CO. LTD: COMPANY SNAPSHOT
TABLE 185.ANJUE MEDICAL EQUIPMENT CO. LTD: OPERATING SEGMENTS
TABLE 186.ANJUE MEDICAL EQUIPMENT CO. LTD: PRODUCT PORTFOLIO
TABLE 187.ANJUE MEDICAL EQUIPMENT CO. LTD: NET SALES,
TABLE 188.ANJUE MEDICAL EQUIPMENT CO. LTD: KEY STRATERGIES LIST OF FIGURES
FIGURE 1.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION
FIGURE 2.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031
FIGURE 3.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIALYSATES AND REPLACEMENT FLUIDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DISPOSABLES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CRRT SYSTEMS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 16.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,BY MODALITY,2021(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH) CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF) CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CONTINUOUS VENOVENOUS HAEMODIALYSIS (CVVHD) CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SLOW CONTINUOUS ULTRAFILTRATION (SCUF) CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 21.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,BY AGE GROUP,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF ADULTS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PEDIATRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031(%)
FIGURE 24.CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY REGION,2021
FIGURE 25.U.S. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 26.CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 27.MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 28.GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 29.FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 30.UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 31.ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 32.SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 34.CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 35.JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 36.INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 37.AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 38.SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 39.REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 40.BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 41.SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 42.SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 43.REST OF LAMEA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,2021-2031($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48.COMPETITIVE DASHBOARD
FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 50.FRESENIUS MEDICAL CARE.: NET SALES ,($MILLION)
FIGURE 51.BAXTER INTERNATIONAL.: NET SALES ,($MILLION)
FIGURE 52.TORAY INDUSTRIES INC..: NET SALES ,($MILLION)
FIGURE 53.SWS HEMODIALYSIS CARE.: NET SALES ,($MILLION)
FIGURE 54.NIPRO CORPORATION.: NET SALES ,($MILLION)
FIGURE 55.NINGBO TIANYI MEDICAL DEVICES.: NET SALES ,($MILLION)
FIGURE 56.NIKKISO CO. LTD.: NET SALES ,($MILLION)
FIGURE 57.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 58.MEDITES PHARMA SPOL. S.R.O.: NET SALES ,($MILLION)
FIGURE 59.MEDICAL COMPONENTS INC..: NET SALES ,($MILLION)
FIGURE 60.MEDICA S.P.A.: NET SALES ,($MILLION)
FIGURE 61.INFOMED SA.: NET SALES ,($MILLION)
FIGURE 62.CYTOSORBENTS.: NET SALES ,($MILLION)
FIGURE 63.CHONGQING SHANWAISHAN SCIENCE AND TECHNOLOGY.: NET SALES ,($MILLION)
FIGURE 64.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
FIGURE 65.ASAHI KASEI CORPORATION.: NET SALES ,($MILLION)
FIGURE 66.ANJUE MEDICAL EQUIPMENT CO. LTD.: NET SALES ,($MILLION